Granulocyte macrophage colony stimulating factor pretreatment induces an increase of rat Kupffer cells with enhanced cytotoxicity in vitro and prevention of tumor outgrowth in vivo

Anti-Cancer Drugs

Volumn 8, Issue 3, 1997, Pages 269-275

  Schuurman, Bart ^a,b   Koenen, Hans J ^a   Beelen, Robert H J ^a   Meyer, Sybren ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b Mariaziekenhuis ^*  (Netherlands)

Author keywords

cytotoxicity; GM CSF; Kupffer cell; liver; minimal residual disease

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; KUPFFER CELL; LIVER METASTASIS; MALE; MINIMAL RESIDUAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL LINE; TUMOR GROWTH;

ANIMALS; CARCINOMA; CELL DEATH; DRUG SCREENING ASSAYS, ANTITUMOR; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; IMMUNOHISTOCHEMISTRY; KUPFFER CELLS; LIVER NEOPLASMS, EXPERIMENTAL; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED STRAINS; TETRAZOLIUM SALTS; THIAZOLES; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0030928447     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199703000-00008     Document Type: Article

References (34)

1. Roska AK, Lipsky PE. Monocytes and macrophages. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge C, eds. Textbook of reumatology, 3rd edn. Philadelphia, PA: WB Saunders 1989: 346-66.
2. Daemen T. Activation of Kupffer cell tumoricidal activity by immunomodulators encapsulated in liposomes. Res Immunol 1992; 143: 205-10.
3. Heuff G, Oldenburg HSA, Boutkan H, et al. Enhanced tumour growth after selective elimination of Kupffer cells. Cancer Immunol Immunother 1993; 37: 125-30.
4. Hill ADK, Redmond HP, Austin OM, Grace PA, Bouchier-Hayes D. Granulocyte macrophage colony stimulating factor inhibits tumour growth. Br J Surg 1993; 80: 1543-6.
5. Metcalf D, Elliot MJ, Nicola NA. The excess number of peritoneal macrophages in granulocyte-macrophage colony-stimulating factor transgenic mice are generated by local proliferation. J Exp Med 1992; 175: 877-84.
6. Metcalf D, Begley CG, Williamson DJ, et al Hemopoietic responses in mice injected with purified recombinant murine GM-CSE Exp Hematol 1987; 15: 1-9.
7. Schuurman B, Heuff G, Beelen RHF, Meyer S. Enhanced cytotoxic capacity of human Kupffer cells after activation with human granulocyte-macrophage colony stimulating factor and interferon-γ. Cancer Immunol Immunother 1994; 39: 179-84.
8. Chachoua A, Oratz R, Hoogmoed R, et al. Monocyte activation following systemic administration of granulocyte-macrophage colony-stimulating factor. J Immunother 1994; 15: 217-24.
9. Wing JW, Magee DM, Whiteside TL, Kaplan SS, Shadduk RK. Recombinant human granulocyte-macrophage colony stimulating factor enchances monocyte cytotoxicity and secretion of tumor necrosis factor and interferon in cancer patients. Blood 1989; 73: 643-6.
10. Ragnhammar P, Masucci G, Frödin JE, Hjelm AL, Mellstedt H. Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1a and granulocyte/macrophage-colony-stimulating factor. Cancer Immunol Immunother 1992; 35: 158-64.
11. Heuff G, van der Ende MB, Boutkan H. et al. Macrophage populations in different stages of induced metastases in rats: an immunohistochemical analysis. Scand J Immunol 1993; 38: 10-6.
12. Fidler IJ, Poste G. Macrophage mediated destruction of malignant tumour cells and new strategies for the therapy of metastatic disease. Semin Immunopathol 1982; 8: 161-74.
13. Herling IM. Decrease in experimental liver metastasis in mice after treatment with pyran copolymer. J Med 1975; 6: 33-40.
14. Holmberg SB, Hafström L, Kjellberg G. RES function and tumour take and tumour growth in the liver and the kidney - an experimental study, Eur J Cancer Clin Oncol 1987; 23: 245-51.
15. Fisher FR, Fisher B. Experimental studies of factors influencing hepatic metastases X. Effect of reticuloendothelial stimulation. Cancer Res 1962; 22: 478-83.
16. Sukumar S, Hunter JT, Nobokumi T, Rapp HJ. Eradication of microscopic hepatic metastases by active specific immunization. Cancer Immunol Immunother 1983; 14: 151-4.
17. Brodt P, Blore J, Philips NC, Munzer JS, Rioux JD. Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptide. Cancer Immunol Immunother 1989; 28: 54-8.
18. Yamashita R, Hiraoka T, Kamimoto T, Miyauchi Y. Prevention of growth of metastases in rat liver by perioperative immunoactivation. Cancer Res 1986; 46: 3138-41.
19. Tanuka A, Suzuki T, Oboshi S. Antitumor activity of macrophages induced by a streptococcal preparation, OK-432. Cancer Chemother 1987; 5: 1233-41.
20. Ishii Y, Yamaoka H, Toh K, Kikuchi K. Inhibition of tumour growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432. Gann 1976; 67: 115-9.
21. Oshimi K, Kano S, Takaku F, Okumura K. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. J Natl Cancer Inst 1980; 65: 1265-9.
22. Sakai S, Ryoyama K, Koshimura S, Migata S. Studies on the properties of a streptococcal preparation OK-432 (NSC B1 16209) as an immunopotentiator. Jpn J Exp Med 1976; 46: 123-33.
23. Kai S, Tanaka J, Nomoto K, Torisu M. Studies on the immunopotentiating effects of a streptococcal preparation, OK-432. Clin Exp Immuno 1979; 37: 98-105.
24. Heuff G, Steenbergen JJE, Van de Loosdrecht AA, et al. Isolation of cytotoxic Kupffer cells by a modified enzymatic assay: a methodological study. J Immunol Methods 1993; 159: 115-23.
25. Marquet RL, Westbroek DL, Jeekel J. Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int J Cancer 1984; 33: 689-92.
26. Van de Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RHJ, Broekhoven G, Langenhuijsen MM. Cell mediated cytotoxicity against U937 cells by human monocytes and macrophages in a modified colonmetric MTT assay: a methodological study. J Immunol Methods 1991; 141: 15-22.
27. Heuff G, Boutkan H, Beelen RHJ, Van Rooijen N, Meyer S, Dijkstra CD. Kinetics and functional role of Kupffer cells in controlling hepatic metastases. In: Knook DL, Wisse E. eds. Cells of the hepatic sinusoid. Leiden: The Kupffer Cell Foundation 1993: 500-3.
28. Dijkstra CD, Döpp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 4: 589-99.
29. Phillips NC. Kupffer cells and liver metastasis. Cancer Metast Rev 1989; 8: 231-52.
30. Roberts S, Long L, McGrath R, McGraw E, Cole WH. The isolation of cancer cells from the blood stream during uterine curettage. Surg Gynecol Obstet 1960; 111: 3-11.
31. Eggermont AMM, Marquet RL, de Bruin RWF, Jeekel J. Effects of the interferon-inducer ABPP on colon cancer in rats: importance of tumor load and tumor site. Cancer Immunol Immunother 1986; 22: 217-20.
32. Ijzermans JNM, Marquet RL, Bouwman E, de Bruin RWF, van der Meide PH, Jeekel J. Successful treatment of colon cancer in rats with recombinant interferon-gamma. Br J Cancer 1987; 6: 795-6.
33. Busch ORC, Slooter GD, Jeekel J, Marquet RL. Effect of Levamisole and 5-fluorouracil on immune status and tumour growth of colorectal carcinoma (CC531) in the rat. Proc Am Ass Cancer Res 1993; 34: 457.
34. Philips NC, Tsao M-S. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative. Cancer Res 1989; 49: 936-9.